Aptamer Sciences Inc (291650)

Currency in KRW
1,125
+11(+0.99%)
Delayed Data·
291650 Scorecard
Full Analysis
Stock has taken a big hit over the last week
291650 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,0531,140
52 wk Range
8033,258
Key Statistics
Bid/Ask
1,121.00 / 1,125.00
Prev. Close
1,114
Open
1,114
Day's Range
1,053-1,140
52 wk Range
803-3,258
Volume
154.36K
Average Volume (3m)
1.71M
1-Year Change
-49.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
291650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Aptamer Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Aptamer Sciences Inc Company Profile

Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company’s platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. Aptamer Sciences Inc was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Compare 291650 to Peers and Sector

Metrics to compare
291650
Peers
Sector
Relationship
P/E Ratio
-−4.9x−0.5x
PEG Ratio
-−0.090.00
Price/Book
-2.3x2.6x
Price / LTM Sales
-19.5x3.2x
Upside (Analyst Target)
-21.1%40.5%
Fair Value Upside
Unlock0.3%4.4%Unlock

Earnings

Latest Release
Mar 01, 2025
EPS / Forecast
-82.05 / --
Revenue / Forecast
920.07M / --
EPS Revisions
Last 90 days

291650 Income Statement

FAQ

What Stock Exchange Does Aptamer Sciences Trade On?

Aptamer Sciences is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Aptamer Sciences?

The stock symbol for Aptamer Sciences is "291650."

What Is the Aptamer Sciences Market Cap?

As of today, Aptamer Sciences market cap is 32.62B.

What Is Aptamer Sciences's Earnings Per Share (TTM)?

The Aptamer Sciences EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 291650 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aptamer Sciences Stock Split?

Aptamer Sciences has split 1 times.

How Many Employees Does Aptamer Sciences Have?

Aptamer Sciences has 0 employees.

What is the current trading status of Aptamer Sciences (291650)?

As of 25 Jul 2025, Aptamer Sciences (291650) is trading at a price of 1,125.00, with a previous close of 1,114.00. The stock has fluctuated within a day range of 1,053.00 to 1,140.00, while its 52-week range spans from 803.00 to 3,258.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.